Support teaching, research, and patient care.
Abha Khandelwal is an imaging cardiologist who has clinical experience in cardio-obstetrics, structural disease and prevention of cardiovascular disease in high risk populations. She has a Master’s in Management of Information Systems and has integrated technology to improve operations within the cardiovascular ambulatory clinics. She serves as the Ambulatory Clinic Chief for Cardiovascular Medicine and the General Cardiology Section Lead. Her research spans clinical trials in preventative cardiology, imaging, cardio-obstetrics and women’s heart health. She has participated in a broad range of phase II- phase III clinical trials targeting treatment of elevated lipoprotein a for secondary prevention of cardiovascular disease, diabetes control in cardiovascular disease and dyslipidemia in high risk populations. She has worked within the Stanford South Asian Translational Heart Initiative (SSATHI) program looking at technology utilization to improve adherence to care plans in the south Asian population. She is the course director for the first annual CME for transforming cardiac rehab in the fall at Stanford. She has utilized digital health initiatives to improve cardiometabolic profile of women with history of gestational diabetes and hypertension post-partum. She is an active member in the AHA go red scientific advisory committee and helped with virtual enrollment for their initiatives. As Ambulatory Clinic Chief, she has worked at operationalizing mobile technology within the clinics and used remote patient monitoring to improve patient outcomes. Her vision is to integrate technology to improve health care delivery, health in high-risk populations, and reduce health disparities.
Cardiovascular disease in PregnancyValvular Heart DiseaseCardiomyopathyPericardial diseaseHeart Disease in South AsiansWomen's Cardiovascular Disease
Early MRI Detection of Myocardial Deterioration as a Preventive, Disease Staging, and Prognostic Biomarker in Insulin Resistance
The purpose of this study is to evaluate the relationship between insulin resistance (IR) and
myocardial tissue abnormalities. The study will focus on a patient population, South Asians,
with a high prevalence of IR.
Stanford is currently not accepting patients for this trial.
For more information, please contact Krystal Solis, 650-723-8138.
View full details